PARAMETRIC PORTFOLIO ASSOCIATES LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 15 filers reported holding Novozymes A/S in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q1 2021$17,420,000
+26.6%
271,428
+12.5%
0.01%
+11.1%
Q4 2020$13,765,000
+6.6%
241,187
+17.6%
0.01%0.0%
Q3 2020$12,913,000
-5.0%
205,171
-12.7%
0.01%
-10.0%
Q2 2020$13,586,000
+10.7%
234,929
-12.9%
0.01%
-9.1%
Q1 2020$12,271,000
-3.8%
269,743
+3.2%
0.01%
+22.2%
Q4 2019$12,753,000
+48.2%
261,273
+27.7%
0.01%
+28.6%
Q3 2019$8,605,000
-24.3%
204,587
-16.3%
0.01%
-22.2%
Q2 2019$11,367,000
+17.1%
244,287
+15.8%
0.01%
+12.5%
Q1 2019$9,710,000
+7.4%
210,978
+4.4%
0.01%
-11.1%
Q4 2018$9,041,000
-36.9%
202,034
-22.8%
0.01%
-30.8%
Q3 2018$14,332,000
+23.9%
261,819
+14.1%
0.01%
+18.2%
Q2 2018$11,570,000
-20.9%
229,418
-18.0%
0.01%
-21.4%
Q1 2018$14,635,000
+13.6%
279,668
+24.0%
0.01%
+7.7%
Q4 2017$12,883,000
+24.7%
225,586
+12.4%
0.01%
+18.2%
Q3 2017$10,330,000
+28.7%
200,732
+9.5%
0.01%
+10.0%
Q2 2017$8,029,000
+21.2%
183,265
+9.7%
0.01%0.0%
Q1 2017$6,622,000
+59.7%
167,001
+39.0%
0.01%
+66.7%
Q4 2016$4,147,000
-24.2%
120,167
-2.5%
0.01%
-25.0%
Q3 2016$5,468,000
-7.5%
123,261
+0.2%
0.01%
-11.1%
Q2 2016$5,909,000
+22.8%
122,968
+14.6%
0.01%
+12.5%
Q1 2016$4,813,000
-18.1%
107,282
-12.9%
0.01%
-20.0%
Q4 2015$5,875,000
+5.3%
123,110
+4.8%
0.01%
-9.1%
Q2 2015$5,578,000
+24.8%
117,449
+20.1%
0.01%
+22.2%
Q1 2015$4,469,000
+20.6%
97,830
+11.2%
0.01%
+12.5%
Q4 2014$3,706,000
+1.4%
87,942
+4.0%
0.01%0.0%
Q3 2014$3,656,000
-7.5%
84,556
+7.6%
0.01%
-11.1%
Q2 2014$3,953,000
+10.9%
78,595
-3.0%
0.01%
+12.5%
Q1 2014$3,563,000
+6.4%
81,061
+2.3%
0.01%0.0%
Q4 2013$3,349,000
+13.1%
79,257
+2.7%
0.01%0.0%
Q3 2013$2,961,000
+13.5%
77,198
-5.0%
0.01%0.0%
Q2 2013$2,609,00081,2620.01%
Other shareholders
Novozymes A/S shareholders Q4 2020
NameSharesValueWeighting ↓
ZEVIN ASSET MANAGEMENT LLC 57,209$2,8870.63%
Boston Common Asset Management, LLC 18,413$9300.04%
GOFEN & GLOSSBERG LLC /IL/ 5,000$2520.01%
MAR VISTA INVESTMENT PARTNERS LLC 273$13,7760.00%
ST GERMAIN D J CO INC 5,000$2520.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,075$155,2970.00%
Financial Avengers, Inc. 10$5050.00%
View complete list of Novozymes A/S shareholders